Mechanisms of in Situ Activation for DNA-Targeting Antitumor Agents
- 15 May 2002
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 102 (7) , 2477-2496
- https://doi.org/10.1021/cr010046q
Abstract
No abstract availableThis publication has 94 references indexed in Scilit:
- The structural basis for in situ activation of DNA alkylation by duocarmycin SAJournal of Molecular Biology, 2000
- High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SAJournal of Molecular Biology, 1997
- EPR spectroscopic investigation of the lability of oxygen in activated bleomycin: Implications for the mechanism of bleomycin-mediated DNA degradationBiochemistry, 1993
- A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-convalent van der waals contacts dominant in the non-covalent CC-1065/B-DNA bindingChemico-Biological Interactions, 1990
- Autocatalytic quinone methide formation from mitomycin cBiochemistry, 1986
- Iron·bleomycin·DNA·system evidence of a long-lived bleomycin·iron·oxygen intermediateBiochemical and Biophysical Research Communications, 1982
- Neocarzinostatin: Controlled release of chromophore and its interaction with DNABiochemical and Biophysical Research Communications, 1981
- The iron complexes of bleomycin and tallysomycinBiochemical and Biophysical Research Communications, 1979
- A role for ferrous ion and oxygen in the degradation of DNA by bleomycinBiochemical and Biophysical Research Communications, 1976
- Hexamethylmelamine.An evaluation of its role in the therapy of cancerCancer, 1976